Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2.09 Billion | USD 3.71 Billion | 6.6% | 2023 |
The global Foot and Mouth Disease Vaccines Market size was valued at USD 2.09 Billion in 2023 and is predicted to reach USD 3.71 Billion by the end of 2032. The market is expected to grow with a CAGR of 6.6% during the forecast period. The report analyzes the global Foot and Mouth Disease Vaccines Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Foot and Mouth Disease Vaccines industry.
Foot and mouth disease is a kind of infection found in domestic animals due to the viral strain. It majorly affects livestock like swine, sheep, goats, cattle, and other animals. It is a communicable disease that can be spread through both indirect and direct modes of contact. Such diseases cause high morbidity that results in a huge economic loss due to chronic mastitis, permanent hoof damage, and reduced milk production.
One of the major factors driving the growth of the global foot and mouth disease vaccine market is the increasing livestock population all across the globe. Moreover, the growing demand for animal-based products especially in western countries is significantly fuelling the growth of the global foot and mouth disease vaccines market. Zoonotic and livestock diseases are vigorously increasing from some past decades due to various factors like rapid globalization and adverse climatic transformations. Several initiatives are undertaken by the government to administer the various healthcare practices adopted by professionals for livestock treatments. Vaccination drive is widely undertaken by organizations and governments to reduce animal loss and treat the various foot and mouth diseases effectively. Such vaccines are more in demand due to the unavailability of proper and permanent treatment for foot and mouth disease.
However, livestock is a very crucial contributor to the country's GDP and hence it needs significant attention for effective treatment in animal healthcare practices. The growing technological advancements in the medical sector to improve the quality of healthcare practices are significantly boosting the growth of the global foot and mouth disease vaccines market. The growing funding from government and prominent market players to boost the research and development activities has significantly contributed towards the growth of the global foot and mouth disease vaccines market.
The global foot and mouth disease vaccine market can be segmented into animals, techniques, and regions.
By animals, the market can be segmented into pigs, sheep & goat, cattle, and others. The cattle segment accounts for the largest share in the global foot and mouth disease vaccines market. The foot and mouth diseases are much prevalent in the cattle segment and hence it possesses greater demand for foot and mouth disease vaccines. Moreover, the sheep segment is anticipated to grow significantly during the forecast period due to the high level of foot and mouth virus presented in the excreta of infected sheep.
By techniques, the market can be segmented into emergency vaccines and conventional vaccines. Conventional vaccines segment holds the largest share in the global foot and mouth disease vaccines market due to the growing adoption of oil-based vaccines. The rising preferences can be attributed to the longer effectiveness and high efficacy of oil-based conventional vaccines. However, the emergency vaccine segment is expected to grow significantly during the forecast period due to the sudden outbreak of foot hand mouth infectious diseases.
Report Attributes | Report Details |
---|---|
Report Name | Foot and Mouth Disease Vaccines Market |
Market Size in 2023 | USD 2.09 Billion |
Market Forecast in 2032 | USD 3.71 Billion |
Growth Rate | CAGR of 6.6% |
Number of Pages | 207 |
Key Companies Covered | Merck Animal Health, Biogenesis Bago SA, Vetal Animal Health Products S.A, Biovencer Healthcare Private Limited, Biovet Private Limited, Boehringer Ingelheim GmbH, Brilliant Bio Pharma Ltd., Ceva Santé Animale, and India Immunological Ltd. |
Segments Covered | By animals, By techniques and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific accounts for the largest share in the global foot and mouth disease vaccine market due to the largest livestock population in the region. Moreover, the presence of prominent market players in the region further boosts the growth of the regional market during the forecast period. Also, the consistent efforts of prominent players to boost the research and development activity to innovate commercialize veterinary vaccines is also driving the growth of the regional market vigorously. However, the urgent need in the region to curb the growing incidences of foot and mouth infectious diseases is likely to propel the growth of the regional market.
North America is anticipated to witness significant growth during the forecast period due to the growing research and development activities to innovate therapeutic options for highly infectious foot and mouth diseases.
Global Foot and Mouth Disease Vaccines Market: Competitive Players and Segments
Some of the significant players in the global foot and mouth disease vaccines market are
By Animals
By Techniques
Global Foot and Mouth Disease Vaccines Market: Regional Segments
What Reports Provides
FrequentlyAsked Questions
One of the major factors driving the growth of the global foot and mouth disease vaccine market is the increasing livestock population all across the globe. Moreover, the growing demand for animal-based products especially in western countries is significantly fuelling the growth of the global foot and mouth disease vaccines market.
Some of the significant players in the global foot and mouth disease vaccines market are Merck Animal Health, Biogenesis Bago SA, Vetal Animal Health Products S.A, Biovencer Healthcare Private Limited, Biovet Private Limited, Boehringer Ingelheim GmbH, Brilliant Bio Pharma Ltd., Ceva Santé Animale, and India Immunological Ltd.
Asia Pacific accounts for the largest share in the global foot and mouth disease vaccine market due to the largest livestock population in the region. Moreover, the presence of prominent market players in the region further boosts the growth of the regional market during the forecast period. Also, the consistent efforts of prominent players to boost the research and development activity to innovate commercialize veterinary vaccines is also driving the growth of the regional market vigorously.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed